BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32320310)

  • 1. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2020 Jun; 36(5):267-268. PubMed ID: 32320310
    [No Abstract]   [Full Text] [Related]  

  • 2. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2020 May; 36(4):199-200. PubMed ID: 32186947
    [No Abstract]   [Full Text] [Related]  

  • 3. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2020 Apr; 36(3):135-136. PubMed ID: 32074465
    [No Abstract]   [Full Text] [Related]  

  • 4. Eyes on New Product Development: Regulations, Generics, and Disruptive Technologies.
    Novack GD
    J Ocul Pharmacol Ther; 2021 May; 37(4):191-192. PubMed ID: 33761283
    [No Abstract]   [Full Text] [Related]  

  • 5. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2017; 33(6):423-425. PubMed ID: 28618236
    [No Abstract]   [Full Text] [Related]  

  • 6. Eyes on New Product Development: Regulations, Generics, and Disruptive Technologies.
    Novack GD
    J Ocul Pharmacol Ther; 2021 Jun; 37(5):249-250. PubMed ID: 33961491
    [No Abstract]   [Full Text] [Related]  

  • 7. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2021 Oct; 37(8):439-440. PubMed ID: 34448621
    [No Abstract]   [Full Text] [Related]  

  • 8. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2015 Oct; 31(8):445-6. PubMed ID: 26367793
    [No Abstract]   [Full Text] [Related]  

  • 9. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2020 Mar; 36(2):73-74. PubMed ID: 31971847
    [No Abstract]   [Full Text] [Related]  

  • 10. Notification vs approval.
    Novack GD
    Ocul Surf; 2007 Jul; 5(3):255-8. PubMed ID: 17660899
    [No Abstract]   [Full Text] [Related]  

  • 11. Food and Drug Administration, partner in drug development.
    Yates JW
    CA Cancer J Clin; 2006; 56(6):321-2. PubMed ID: 17135690
    [No Abstract]   [Full Text] [Related]  

  • 12. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2019 Dec; 35(10):523-524. PubMed ID: 31644360
    [No Abstract]   [Full Text] [Related]  

  • 13. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2015 Dec; 31(10):587-8. PubMed ID: 26562091
    [No Abstract]   [Full Text] [Related]  

  • 14. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2013 Jun; 29(5):449. PubMed ID: 23725200
    [No Abstract]   [Full Text] [Related]  

  • 15. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2019 Nov; 35(9):467-468. PubMed ID: 31682182
    [No Abstract]   [Full Text] [Related]  

  • 16. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2019 Jun; 35(5):263-264. PubMed ID: 30994391
    [No Abstract]   [Full Text] [Related]  

  • 17. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2019 Apr; 35(3):137. PubMed ID: 30785810
    [No Abstract]   [Full Text] [Related]  

  • 18. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):611. PubMed ID: 23981251
    [No Abstract]   [Full Text] [Related]  

  • 19. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2019 May; 35(4):201-202. PubMed ID: 30896288
    [No Abstract]   [Full Text] [Related]  

  • 20. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2013; 29(6):513-4. PubMed ID: 23841863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.